Filed under: Drug Safety, genetic medicine, Online Data sharing, open access database, open source, oracle, Oracle Health Sciences Global Business Unit, Patient Safety, personalized medicine, Pharmacogenomics, pharmacovigilance | Tagged: Drug Safety, health sciences global business unit, HSGBU, OHSI, Open Source Drug Development Network, oracle, Oracle Health Science Global Business Unit, Oracle Health Sciences Institute, personalized medicine, Pharmacogenomics, pharmacovigilance, Sun Labs | 1 Comment »
Grid computing projects supported by Big Blue announced significant progress in looking for new potential drugs in cancer treatment
Filed under: cloud computing, collaborative research, open source, SaaS, web2.0 | Tagged: cloud computing, grid computing, health sciences global business unit, lifescience cloud, open source, Oracle health sciences global business unit, SaaS | Leave a comment »
The Australian Research Collaboration Service (ARCS) www.arcs.org.au has launched its Computer Cloud scheme, a $22 million project funded by the government’s National Collaborative Research Infrastructure Strategy.
More details check http://www.arcs.org.au/index.php/services/cloud-computing
Bob Correll, the chief information officer for the Department of Immigration and Citizenship, said his agency is also looking into using cloud computing for its electronic visa system
Filed under: clinical software, cloud computing, lifescience, Online Data sharing, open source, SaaS | Tagged: health sciences global business unit, Oracle health sciences global business unit | Leave a comment »
Succeeding at open-source innovation: An interview with Mozilla’s Mitchell Baker and the USD $34 million Indian Government plan for Opensource Drug Development
Benjamin Franklin said “As we enjoy great advantages from the inventions of others we should be glad of an opportunity to serve others by any invention of ours; and this we should do freely and generously.” – Any one listening !
Leaders and veterans in Biotechnology and Health care research industry may not be welcoming open source ideals. But IT industry has set new benchmarks and proved that open source brings in much needed new ideas and innovation. So hear out loud from none other than chairman and former CEO of Mozilla. The article is published for free at the Mckinsey quarterly
Mitchell comments that Mozilla’s real contribution isn’t just the browser but the model of participation.
In 2005 annual report on Association of American Medical Colleges acknowledged that industry, academic and government researchers can and must work together to remove scientific hurdles in drug development.
For hte uninitaited a look at the article published in Nature Magazine in 2006 with help from Pharma major Eli Lilly-Open source R&D and collaborative drug discovery and other related blogs MnDoci FuturePundit
And don’t think these are just rants of an overenthusiastic researchers, who doesn’t know the dynamics of business, why because Director-General of the Council for Scientific and Industrial Research (CSIR) in, India unveiled a USD $34 million plan for Open Source Drug Discovery. CSIR is one of the world’s largest publicly funded R&D organisations 38 laboratories working on a range of subjects from molecular biology to road research to Himalayan bio-resources. The Council has more than 4,000 scientists working for it at these 38 labs.
The January 18 2008 meeting in NewDelhi in India was organized by Knowledge Commons, Delhi Science Forum, IIT Delhi, Red Hat and Sun on Free and Open Source model of knowledge. The highlight of the event was opensource drug development — make sure you read the Opensource India blog by Venkatesh
CSIR’s chief Sameer K. Brahmachari says, he looks for “taare zameen par” (stars on earth, a reference to one of Bollywood’s latest blockbusters), in large numbers
OSDD has the support of Sun Microsystems Inc. Hewlett-Packard, IIT Delhi, Red Hat and Indian corporate houses like TCG Life Sciences.
“Great discoveries and improvements invariably involve the cooperation of many minds. I may be given credit for having blazed the trail, but when I look at the subsequent developments I feel the credit is due to others rather than myself.’